Xiaohua Dai Selected Research

Xiaohua Dai Research Topics

2	Heart Failure 05/2022 - 12/2020
2	Vascular System Injuries 12/2020 - 01/2017
1	Heart Diseases (Heart Disease) 05/2022
1	Fibrosis (Cirrhosis) 05/2022
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 05/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Myocardial Infarction 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Acute Coronary Syndrome 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Inflammation (Inflammations) 01/2017
1	Breast Neoplasms (Breast Cancer) 09/2016
1	Abdominal Aortic Aneurysm 05/2015
1	Bone Diseases (Bone Disease) 11/2014
1	Infections 01/2014
1	Fahr's disease 02/2012
1	Ocular Albinism 01/2007

2	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2016
2	Carrier Proteins (Binding Protein)IBA 01/2017 - 09/2016
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2016 - 01/2014
1	Dynamins (Dynamin)IBA 05/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2022
1	Adenosine Triphosphate (ATP)IBA 05/2022
1	acteinIBA 01/2021
1	tanshinone II A sodium sulfonateIBA 01/2021
1	Differentiation AntigensIBA 12/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2020
1	qishen yiqiIBA 12/2020
1	Contrast MediaIBA 01/2019
1	CreatinineIBA 01/2019
1	transgelinIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	CytokinesIBA 01/2017
1	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 05/2015
1	CollagenIBA 05/2015
1	Biological ProductsIBA 11/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	EnrofloxacinIBA 01/2014
1	Phosphates (Orthophosphate)IBA 02/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2007

1	Moxibustion 05/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2022
1	Percutaneous Coronary Intervention 01/2021
1	Stents 01/2021
1	Emergency Treatment 12/2020
1	Therapeutics 11/2014